Introduction
Fungi have long been regarded as a source of natural medicine, and mushrooms used for medicinal purposes feature prominently in Traditional Asian Medicine (Hapuarachchi et al. 2018b , Hyde et al. 2019 . Over the last four decades, various therapeutic activities have been reported as a result of extensive research on mushrooms using in vitro assays, in vivo animal models, and, in some cases, human clinical studies; these include but are not limited to : anti-cancer, anti-diabetic, anti-malarial, anti-microbial, antioxidant, anti-tumor, anti-viral, neuroprotective, and hypocholesterolemic properties (De Silva et al. 2012a , b, 2013 , Dalonso et al. 2015 , Thongbai et al. 2015 , Hapuarachchi et al. 2016 , Klupp et al. 2016 , Wasser 2017 , Hapuarachchi et al. 2018a ). In the Mycosphere X(X): X-X (2019) www.mycosphere.org ISSN 2077 7019 Article Doi 10.5943/mycosphere/X/X/X waste, rice straw, wood chips, and sawdust are commonly used for the production of Auricularia species (Peng 2008) . Optimal culture conditions (temperature, pH) with nutritionally rich supplementation are necessary for increasing the yield as well as commercial quality of edible mushrooms (Carrasco et al. 2018) . The substrate supplementation is known to impact the nutritional content of Auricularia. For example, the use of 60% sugarcane bagasse resulted in the highest nutrient output (carbohydrates, protein, ash, and fat) from A. polytricha in contrast to other agro-waste substrates such as rice straw, and rice husk (Wu et al. 2017 ). On the other hand, A. auricula grown on maize cobs and wheat bran showed higher nutrient content (cellulose, proteins and moisture) in contrast to the counterparts grown on saw dust and rice bran in Kenya (Onyango et al. 2011) . The dry biomass weight that represent the content of moisture, crude proteins, ash and carbohydrates has also been reported to be dependent on the type of nutrient medium used for their cultivation. For instance, nitrogen source that was most favorable for A. polytricha growth and highest dry biomass production was yeast extract in contrast to reducing impact from tryptone, beef extract and peptone (Hassan & Medany 2012) .
The wide range of growing conditions and methods used for production also provides implications on the environmental plasticity of Auricularia sp. It also coincides with the high degree of interspecies and intraspecies genetic diversity. Past studies have shown that intraspecies and interspecies genetic diversity is quite high, and this may impact their breeding and cultivation conditions (Yan et al. 2004 , Li et al. 2007 , Du et al. 2013 , Li et al. 2014 . In order to address this intraspecies genetic variability, new techniques employing random amplified polymorphic DNA (RAPD) fingerprinting analysis have been shown to be highly successful in determining the genetic diversity of A. auricula and A. polytricha strains, and have been suggested as an effective method for determining breeding techniques (Yan et al. 2004) .
Auricularia as an edible mushroom
Auricularia is a cosmopolitan genus, comprised of eighteen species (Bandara et al. 2017b) of which Auricularia auricula-judae ( ull r ) u l., [= A. auricula (L. ex Hook.) Underw.], A. cornea (Ehrenb.) Fr., A. delicata (Mont. ex Fr.) Henn., A. fuscosuccinea (Mont.) Henn., A. heimuer F. Wu, B.K. Cui, Y.C. Dai, A. thailandica Bandara & K.D. Hyde and A. villosula Malysheva have been reported as edible species (Fig. 1) (Zent et al. 2004 , Wu et al. 2014 , Sekara et al. 2015 , Zhang et al. 2015a , Bandara et al. 2017a , Kamalebo et al. 2018 , Zhang et al. 2018b ). The characteristic flavor, along with the slippery and crunchy texture of the gelatinous fruiting body of Auricularia species accounts for the popularity and high consumption in China and Southeast Asia (Misaki & Kakuta 1995 , Cheung 2013 , Jo et al. 2014 .
Nutrient composition of Auricularia
The nutritional content of edible Auricularia varies according the species. On average, dried Auricularia have an approximate composition of 79.9-93.2% carbohydrates, 6.5-13% crude proteins, 9.9-17.9% total soluble sugars, 0.48-4.5% crude fat (lipid), and 3.5-12.5% crude fiber (Table 1) (Crisan & Sands 1978 , Cheung 1997 , Mau et al. 1998 , Chen et al. 2011 , Kadnikova et al. 2015 , Bandara et al. 2017a , USDA 2018a . Carbohydrates are the major components in Auricularia. For example, proximate composition of A. auricula-judae represents carbohydrate: 81.0%, crude protein: 8.1%, crude fat: 1.5%, crude fiber: 6.9%, and ash: 9.4% (Chang & Hayes 2013 , Cheung 2013 .
Digestible nutrients found in edible mushrooms vary depending on the species, age, and their cultivation methods, and include major nutrients such as carbohydrates, proteins, and minerals (Ca, Na, K, and Mg) (Kadnikova et al. 2015) . The digestable carbohydrates are primarily composed of polysaccharides and include water soluble mannans and glucans, pectins, chitin, and cellulose whose diegstibility may vary depending on the percentage of these contents (Kadnikova et al. 2015) . The extent of lignification also determine the digestability. However, the non-digestable nurtients such as non-starch polysaccharides represented by fibres are useful as a food source with higher health benefits (Cheung 2013) . In addition to these macronutrients, edible mushrooms provide a good source of micronutrients for which most human diets are deficient such as Se, Cu and Zn (Carrasco et al. 2018) . Moreover, Auricularia species are known to be a source of many minerals that may help to solve human nutrient deficiencies including Mg, Ca, Fe, Zn, Mn, Cu, Ni and Cr (Shin et al. 2007 , Kadnikova et al. 2015 . As with other wild and cultivated edible mushrooms (Kalač 2010 , Kalač 2013 , Wang et al 2014 , potassium is the most prevalent macroelement within Auricularia species (Afiukwa et al. 2013 , Bandara et al. 2017a , USDA 2018a , which are typically nutrient-rich with other macro-elements including Ca, Na, Mg, and P (Table 3 ) (Afiukwa et al. 2013 , Bandara et al. 2017a ). Among micro-elements, high concentrations of Fe and Zn have been reported in Auricularia (50-200 mg/kg), while those of Co, Cr, Cu, Mn and Ni were found to be less than 20 mg/kg of dry weight (Kadnikova et al. 2015 , Bandara et al. 2017a . Studies also suggest an intraspecies variability of micronutrients content of Mg, Mn, Zn, Ni, Cr, Sr in A. auricula where as the Fe levels were quite similar among all the strains with a maximum concentration of 285 µg/g (Li et al. 2018) .
Auricularia is also a rich source of dietary fiber (Cheung 2013) . Most of the carbohydrates in Auricularia have been reported to be indigestible polysaccharides, such as β-glucans and mannans (Misaki & Kakuta 1995 , Mironczuk-Chodakowska et al. 2017 ). Auricularia species have been shown to contain a higher fiber content than other commercially available mushrooms such as Agaricus bisporus and Ganoderma lucidum (Misaki & Kakuta 1995 , Cheung 1997 .
Auricularia species have very low soluble sugar content, which is reflected in their flavor (Mau et al. 1998 ). Furthermore, unlike other edible mushrooms, Auricularia have a low fat content (Cheung 2013) , and 60% of the fatty acids of harvested wild Auricularia are unsaturated (Kavishree et al. 2008) . Low-fat diets with a high content of unsaturated fatty acids are recommended for people with high blood cholesterol, making Auricularia an ideal food choice for them (Lichtenstein et al. 2006 , Chen et al. 2011 .
Quantities of crude proteins in Auricularia species are lower than in most wild and cultivated edible mushroom species (Fan et al. 2006 , Liu et al. 2009 , Cheung 2013 . Common edible mushrooms in the market, such as A. bisporus, Lentinula edodes, and Pleurotus spp. contain 10.5-34.8% of crude protein, whereas A. auricula-judae contains 8.1% of crude protein (Chang & Miles 2004 , Cheung 2013 . Edible species of Auricularia provide 17-18 amino acids, including eight essential amino acids and three semi-essential amino acids (arginine, cysteine, and tyrosine), all of which are of value for pediatric nutrition (Table 2) (Afiukwa et al. 2015 , Bandara et al. 2017a , Ohiri & Bassey 2017 . Glutamic acid was the most abundant amino acid present in Auricularia, whereas sulfur-containing amino acid (cysteine, methionine) quantities were shown to be relatively low ( 
Medicinal properties and pharmacological applications of Auricularia
Auricularia species have long been used as traditional remedies in Asia, European folk cultures, African communities, as well as among indigenous groups such as the Māori (New Zealand) and Tzeltal (Mexico) (Fuller et al. 2004 , Guzmán 2008 , Pala et al. 2013 , Sekara et al. 2015 , Teke et al. 2018 . As an example, A. cornea has been used as a traditional medicine to heal poisoning by toxic plants among Māori tribes (Fuller et al. 2004 , Fuller et al. 2005 , and certain Auricularia species have been used by the Tzeltal people to treat anxiety as part of their traditional medicine (Guzmán 2008) . However, the application of Auricularia for treatment of human disease has moved beyond the domain of traditional medicines and is now being incorporated into Western medicine.
In A. auricula-judae, the major polysaccharide constituents of the fruiting body contained water-soluble glucan I with β-D-configuration ( Fig. 2.1) ; alkali-insoluble glucan II with β-Dglucosidic linkages (Fig. 2 .2); and acidic heteropolysaccharides, which were a mix of xylose, mannose, glucose and glucuronic acid (1.0: 4.1: 1.3: 1.3) (Table 4) (Sone et al. 1978) . Watersoluble glucan I with branched (1→3)-β-D-glucan has been shown to have anti-tumor effects against sarcoma in mice (Table 4) (Misaki et al. 1981) .
Numerous studies have reported on the medicinal properties and pharmacological activities of isolated compounds or different solvent extracts from Auricularia (Sekara et al. 2015) . In particular, the anti-coagulant (Yoon et al. 2003) , anti-inflammatory (Ukai et al. 1983a , Kiho et al. 1985 ), anti-microbial (Gbolagade & Fasidi 2005 , antioxidant (Sun et al. 2010 , Bandara et al. 2017a , anti-tumor (Misaki et al. 1981 , Ukai et al. 1983b ), anti-viral (Nguyen et al. 2012a) , and immunomodulatory (Sheu et al. 2004) activities of Auricularia have been demonstrated. In addition, Auricularia has the potential to treat both hypoglycemia (Yuan et al. 1998a ) and hypolipidemia (Reza et al. 2015) , as well as lowering cholesterol levels (Table 5 ) (Misaki & Kakuta 1995 , Chen et al. 2008 , Zhao et al. 2015 . Furthermore, research has shown that Auricularia mushrooms have the ability to modulate interstitial microbiomes; for instance, A. auricula had a negative impact on Fusobacteriales and a positive impact on Bifidobacteriales and Bacteroidales, two of the most important probiotics (Zhao et al. 2018) .
The high fiber content of Auricularia has been shown to contribute to preventing gastric disorders (Misaki & Kakuta 1995) , such as functional constipation in humans (Kim et al. 2004) . Fibers from Auricularia have also been used to treat gastric disorders associated with nausea (Khan et al. 2016 ). In addition to helping with gastric disorders, the dietary fibers in Auricularia are known to be bioactive compounds with antioxidant and hypocholesterolemic properties (Cheung 1996) .
Previous studies have mentioned the promising effects of Auricularia as an anti-cancer and anti-tumor agent ( Table 5 ) (Misaki & Kakuta 1995 , Ma et al. 2010 , Song & Du 2012a ). Due to the growing evidence that Auricularia species are able to treat gastric disorders, compounds derived or extracted from Auricularia have been used in anti-gastrointestinal cancer therapy, including treatments for colorectal, gastric, liver, pancreatic, and esophageal cancer (Yu et al. 2014 , Ma et al. 2018 . For example, A. polytricha crude polysaccharide extract with a (1→3)-linked-β-Dglucopyranosyl and (1→3, 6)-linked-β-D-glucopyranosyl residue backbone (2:1 ratio) and a terminal (1→)-β-D-glucopyranosyl was shown to inhibit S180 sarcoma cancer transplanted in mice, providing evidence of its anti-cancer properties (Song & Du 2010) . Similarly, sarcoma 180 solid tumors could be inhibited by water soluble and ethanol extracts of polysaccharides from A. auricula-judae through the inhibition of acinar cell carcinoma proliferation and tumor cell apoptosis mediated by reduced Bcl-2 gene expression and increased Bax expression. A recent meta-analysis provided strong evidence for the use of polysaccharides from A. auricula (Huaier) in anti-gastrointestinal cancer therapy (Ma et al. 2018 ). Fermentation of A. auricula followed by hot water extraction gives rise to Huaier cream, which is then mixed with powdered sugar, dextrin, and auxiliary materials to generate Huaier granule. Ma et al. (2018) describes Huaier granules as possessing not only anti-cancer properties but also antioxidant and anti-coagulant activities (Ma et al. 2018 ). The article cites several studies that have used either the Huaier granule or Huaier cream to treat esophageal, pancreatic, gastric, colorectal and hepatocellular cancers (Ma et al. 2018) . Moreover, A. auricula-judae ethanol extract has been used to generate a dichloromethane fraction, which contains diazene, a compound known to be used in treating tumors. The dichloromethane fraction was able to inhibit bronchoalveolar cancer and gastric cancer cells by controlling the levels of tumorigenic genes, including p53 overexpression and Bcl-2 downregulation, to induce cytotoxicity and apoptosis, respectively (Reza et al. 2014 ).
Polysaccharides of Auricularia
Polysaccharides are considered to be the most potent group of bioactive compounds found in mushrooms (Friedman 2016 , Singdevsachan et al. 2016 , Sánchez 2017 , serving as the structural components of the cell wall (Zhang et al. 2007 , Dalonso et al. 2015 and as carbohydrate reserves in sclerotia (Stone 2009 ). Polysaccharides seem to be the major constituents of Auricularia and are classified as homopolysaccharides or heteropolysaccharides based on their monomeric composition (Sone et al. 1978 , Misaki et al. 1981 Homopolysaccharides, composed of β-(1→3)-linked Dglucopyranosyl backbone substituted (1→6)-linked β-D-glucopyranosyl groups, were the most abundantly found macromolecules in most of the edible, medicinal mushrooms (Sone et al. 1978 , Misaki & Kakuta 1995 , Dalonso et al. 2015 , Friedman 2016 , including Auricularia species such as A. auricula-judae (Sone et al. 1978 , Misaki et al. 1981 , Misaki & Kakuta 1995 , A. polytricha (Song & Du 2010) , and Auricularia sp (Yū ěr) (Kiho et al. 1987 , Kiho et al. 1991 . Glucan I (Fig.  2 .1) and Glucan II ( Fig. 2 .2) homopolysaccharides were isolated from the fruiting body of A. auricula-judae composed of β-(1→3)-linked D-glucopyranosyl backbone substituted (1→6)-linked β-D-glucopyranosyl groups (Sone et al. 1978 , Misaki et al. 1981 , Misaki & Kakuta 1995 . Homopolysaccharides composed of different conformations and different linkages of Dglucopyranosyl backbones were reported from A. polytricha AAPS-1 ( Fig (Table 4) .
Polysaccharides consisting of more than one sugar or sugar derivative are called heteropolysaccharides (Enshasy & Hatti-Kaul 2013 , Davidson 2018 . Heteropolysaccharides composed of α-(1→3)-linked D-mannopyranosyl backbones ( Fig. 3.1) , with the branches of Dglucopyranosuronic acid, D-mannopyranose and D-xylopyranose residues [i e α-(1→3)glucuronoxylomannans], which contained a small proportion of D-glucopyranose, were reported from A. auricula-judae (Sone et al. 1978 , Misaki et al. 1981 , Ukai et al. 1982 , Misaki & Kakuta 1995 Though the α-(1→3)-linked D-mannopyranosyl backbone was reported for several fungal heteropolysaccharides (Sone et al. 1978) , α-(1→3)-glucuronoxylomannans were found to be specific to jelly mushrooms (Kakuta et al. 1979 , Wasser 2002 α-Configuration of the (1→3)linked D-mannopyranosyl residues possess a single chain, which leads to the absence of its antitumor potential, while the β-configuration, which has a triple helical structure, is necessary to produce anti-tumor and immunomodulating activity (Misaki et al. 1981 , Misaki & Kakuta 1995 , Enshasy & Hatti-Kaul 2013 . Heteropolysaccharides with β-configuration glucopyranosyl residues were also detected from A. auricula-judae (Table 4) (Ma et al. 2008 , Yang et al. 2011 ). The watersoluble β-D-glucan isolated from A. auricula-judae was composed of β-(1→4)-linked Dglucopyranosyl backbone with β-(1→6)-linked glucopyranosyl side groups at C-6, including glucuronic acid (Ma et al. 2008) A backbone similar to β-D-glucan isolated from A. auricula-judae ( Fig. 3 .2) (Ma et al. 2008 ) was observed in the polysaccharopeptide Krestin isolated from Coriolus versicolor (Ooi & Liu 2000) Although the branching pattern of β-(1→6)-linked glucopyranosyl side groups of β-D-glucan isolated from A. auricula-judae and Krestin isolated from C. versicolor differed from one another, both polysaccharides acted as potential anti-tumor agents (Ma et al. 2010 , Maehara et al. 2012 .
The majority of polysaccharides isolated from fungi are water insoluble; among watersoluble polysaccharides, most are heteropolysaccharides, having a complicated structure and thus making it difficult to elucidate their primary and secondary structures (Ma et al. 2008) . In general, mushroom polysaccharides are highly diversified in their sugar composition, main chain polymer structure, degree of branching, conformation, molecular weight, and other physical properties, all of which significantly influence the bioactivity and mode of action of the polysaccharide (Enshasy & Hatti-Kaul 2013) . It should be noted that different extraction methods and different materials affect the polysaccharide concentration of A. auricula (Li et al. 2019) . The results showed that the enzyme-based extraction was better than either ultrasonic-assisted extraction or water extraction technique. The extraction process of polysaccharides affects the bioactive molecule content of the mushroom extracts and then their biological activities, for any therapeutic target (Li et al. 2019) .
Bioactive polysaccharide properties of Auricularia and potential novel drug therapeutic uses
The following section describes the different bioactive properties of polysaccharides derived from Auricularia species, including anti-cancer, anti-tumor, immunomodulatory, antibacterial, anti-viral, antioxidant, hypoglycemic, and anti-hypercholesterolemic properties. It should be noted that it is currently unknown whether all Auricularia species possess each of these properties. In some cases, the polysaccharides have to be chemically modified (e.g. sulfation) to enhance a certain property, such as the anti-viral properties of A. auricula polysaccharides (Nguyen et al. 2012a) . Although certain of these compounds are already used in treating disease, there are others that are still in experimental stages of development, determining potential medicinal and pharmaceutical applications in the future. In addition to the different medical properties of these polysaccharides, the factors that may influence their activity are also discussed here. The properties of Auricularia polysaccharides are summarized in Fig. 4 .
Polysaccharides with anti-cancer or anti-tumor properties
Many Auricularia polysaccharides have anti-tumor properties that are mediated through (1→3)-β-D-glucan molecules, which induce cancer cell apoptosis [reviewed in (Meng et al. 2016) ]. Auricularia polytricha polysaccharides were shown to inhibit cancer activities in A549 human lung cancer cells by inhibiting DNA synthesis, cell cycle arrest, and cell proliferation, thus indicating their potential as a chemotherapeutic agent in combating lung cancer (Yu et al. 2014 ). The incorporation of these compounds into unique drug delivery systems can enhance their effectiveness. One such example is the use of the Huaier granules for gastrointestinal cancer (Ma et al. 2018 ). The folic acid conjugated Auricularia auricula polysaccharide, cisdiaminedichloroplatinum complex, is a good example of an enhanced polysaccharide that utilizes a drug delivery system to increase its anti-tumor potency while reducing its cytotoxicity in treating cervical carcinoma (Qiu et al. 2018) . Additionally, water, ethanol, ethyl acetate, dichloromethane, and butanol can be used as solvents for the extraction of bioactive compounds from Auricularia, i e , (1→3)-and (1→6)-β−D-glucan-containing polysaccharides are extracted from A. auriculajudae in dichloromethane fraction, which has been identified as an anti-tumor candidate for treating sarcoma 180 cells . Auricularia polytricha polysaccharides have also been shown to have anti-tumor effects against sarcoma (Yu et al. 2009 ). An in vivo anti-tumor test conducted in mice with sarcoma 180 tumors showed that the polysaccharides have anti-tumor effects by activating the functions of macrophages (Yu et al. 2009 ). A polysaccharide main chain composed of (1→4)-linked D-glucopyranosyl and (1→6)-linked D-glucopyranosyl with a branch at O-6 from A. auricula-judae was also shown to have anti-tumor capabilities which are mediated through cancer cell apoptosis [reviewed in (Meng et al. 2016) ]. The cytotoxic properties of A. auriculajudae are also used to inhibit cancer cells derived from the HCT116 cell line, while depending on the extraction method that renders polarity of the bioactive compounds provided them with additional cytotoxic [non polar (n-hexane) extract], anti-oxidative [ethyl acetate and methanol extracts], and anti-diabetics [ethyl acetate extract] properties (Elkhateeb et al. 2018) .
Polysaccharides with anti-bacterial properties
Hot water extraction, followed by alcohol precipitation, was used to collect crude polysaccharides of A. auricula-judae, which were then investigated for anti-microbial capacities (Cai et al. 2015) . These polysaccharides derived from A. auricula-judae were shown to inhibit the activities of Escherichia coli and Staphylococcus aureus, confirming their anti-microbial activity (Cai et al. 2015) Chitosan is an organic polymer and a linear polysaccharide [β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine] that is commercially available and used to treat many diseases, including obesity and hypercholesterolemia. However, chitosan exhibiting a higher degree of deacetylation compared to commercially available forms was extracted from Auricularia species in a recent study (Chang et al. 2019) . The work of Chang et al. (2019) showed that the high deacetylation power of Auricularia chitosan inhibited the growth of E. coli and S. aureus, further confirming the anti-bacterial properties of Auricularia polysaccharides. Moreover, adding low molecular weight chitosan (positively charged) to A. auricula polysaccharides (negatively charged) to create novel polyelectrolyte complex nanoparticles proved to be an ideal delivery system for protein drugs, expanding the potential uses of Auricularia polysaccharides in developing novel drug therapies (Xiong et al. 2016) .
Polysaccharides with anti-viral properties
Auricularia auricula has been used to extract total A. auricula polysaccharides (known as AAPt), which can then be sulfated to enhance their anti-viral activity. The ability of sulfated AAPt in inhibiting the activity of Newcastle Disease Virus on cultured chicken embryo fibroblasts measured using MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay provides evidence for its anti-viral activity (Nguyen et al. 2012a ). The authors refer to the sulfated AAPt as "the component of a new-type anti-viral drug" (Nguyen et al. 2012a ). Studies on anti-viral properties of Auricularia species are still rare. However, the proven anti-viral properties of many fungal species within Basidiomycota in inhibiting a wide range of viruses including BoHV-1, H1N12, HBV, HCV, HIV, Influenza, Polio, and Vaccinia highlight the potential for Auricularia species to provide similar defenses against these viruses, and their potential applications in treating a wide range of viral diseases (Linnakoski et al. 2018) .
Polysaccharides with immunomodulatory properties
The AAPt from A. auricula also showcase immuno-enhancing activities when modified by sulfation using the chlorosulfonic acid-pyridine method (Nguyen et al. 2012b ). Both in vitro and in vivo experiments suggest the use of sulfated AAPt (sAAPt) as an "immunopotentiator" (Nguyen et al. 2012b) . A submerged culture of A. auricula-judae containing exopolysaccharides (CEPSN-1 and CEPSN-2) with (1→4)-α-D-glucose backbones was used by Zhang et al. (2018a) to demonstrate their immunomodulatory activities. Even though the polysaccharide backbone structures differed between the fruiting bodies and the submerged cultures of A. auricula-judae, the exopolysaccharides showed potential immunomodulatory activities (Zhang et al. 2018a ). This observation suggests that immunomodulatory drugs could be generated using exopolysaccharides from submerged cultures of A. auricula-judae.
Inflammation is a natural response to a weakened immune system, and many Auricularia species such as A. polytricha have anti-inflammatory properties that arise not only from their polysaccharides but also other bioactive compounds such as carotenoids, fatty acids, vitamins, and phenolic compounds (Muszynska et al. 2018) . For example, A. auricular-judae polysaccharides have shown protective effects in rats who have acute lung injury induced by lipopolysaccharide which was illustrated by the reduced lung edema and lowered levels of inflammatory mediators (Zhuan Yun et al. 2015) . Similarly, A. auricular-judae polysaccharides were able to inhibit edema (carrageenin-induced) and hyperalgesia (scald-induced) in rats through its anti-inflammatory properties (Ukai et al. 1983a ). The medicinal implications of Auricularia polysaccharides were further illustrated using a rat model of non-alcoholic fatty liver disease who were treated with a diet containing water extract of A. polytricha that is rich in polysaccharides, phenolic compounds and tannins with anti-inflammatory properties. The rats who received the A. polytricha-containing diet showed slowed progression of liver disease in association with elevated anti-oxidative markers suggesting the use of Auricularia supplementation as a potential remedy (Chiu et al. 2014 ). As the same disease model showed attenuation of lipid deposition, the study also provides implications of Auricularia supplementation in treating obesity. The anti-inflammatory as well as antioxidant (discussed below) properties of Auricularia polysaccharides may also render cardio-protective properties to them providing insights into using these polysaccharides for cardiovascular diseases (Hao 2014) .
Polysaccharides with antioxidant properties
Auricularia species have been reported to possess polysaccharides with antioxidant properties, and examples include A. auricula (Xu et al. 2016) and A. polytricha (Avci et al. 2016) . In addition to different species providing different antioxidants, the potential for antioxidant production can also vary according to the strain of a given Auricularia species (Xu et al. 2016 ). Regardless of the differences observed among varieties, the proven antioxidant ability of A. auricula polysaccharides in improving heart functions in a mouse model (Wu et al. 2010 ) have significant implications for the use of Auricularia polysaccharides as pharmaceutical antioxidants for cardiovascular disease treatments. In addition, experimental studies using diabetic mice (in vivo) showed that the polysaccharides of A. auricula were able to modulate anti-oxidative systems and treat diabetic conditions (Hu et al. 2017) . Polysaccharides from A. polytricha were extracted using ethanol and distilled water, and an assessment of their antioxidant activity demonstrated that water-based extraction was more efficient for obtaining higher antioxidant activity when compared to ethanol extraction (Avci et al. 2016 ). These animal model-based studies as well as in vitro assays provide further evidence that polysaccharides of Auricularia may be used in humans after their advancement into clinical trials. Antioxidants may perform its functions through radical scavenging. For example, sulfated neutral and acidic A. auricula polysaccharides showed high radical scavenging abilities which have tremendous implications in disease conditions caused by oxidative stress and generation of free radicals such as Alzheimer's disease and cancer (Zhang et al. 2011) . The free radical scavenging properties of A. auricula were shown to be useful not only as a medicine but also a functional food when it used as a pickled product (Khaskheli et al. 2015) .
Polysaccharides with anti-hypercholesterolemic properties
Polysaccharides extracted from Auricularia have the potential to reduce cholesterol, thus indicating the potential for use in the treatment of hypercholesterolemia. Several animals, including rats and mice, have been used in experiments demonstrating the anti-hypercholesterolemic properties of Auricularia polysaccharides. For example, a diet-induced hypercholesterolemic rat was orally administered with soluble polysaccharides from Auricularia polytricha, resulting in a reduction in blood lipid levels, thereby confirming the natural anti-hypercholesterolemic properties of Auricularia polytricha (Table 5) (Zhao et al. 2015) . Similarly, hypercholesterolemic rats fed with an A. auricula diet in dry powder form had reduced levels of serum LDL cholesterol, as well as lower fecal neutral steroids and bile acids, all of which suggest its effectiveness in reducing hypercholesterolemic activity (Cheung 1996) . Further evidence for the hypocholesterolemic capacities of Auricularia was provided when hot water-extracted polysaccharides from A. auricula were orally administered to hypercholesterolemic mice, and total cholesterol and high-density lipoprotein cholesterol were significantly reduced (Chen et al. 2008) .
Polysaccharides with hypoglycemic properties
Bio-compounds with hypoglycemic properties are important in the treatment of diabetes. Auricularia auricula polysaccharides-simulated-hydrolysates are bio-compounds with hypoglycemic properties, and intragastric administration of A. auricula polysaccharides-simulatedhydrolysates has been suggested as a potential treatment for diabetes mellitus (Lu et al. 2018b) . A model incorporating diabetic mice (diet-streptozotocin-induced) was used to test the anti-diabetic capabilities of A. auricula polysaccharides. These polysaccharides were reported to reduce blood glucose levels in the mice, producing a result similar to the well-known anti-diabetic medicine Metformin (Hu et al. 2017) ; however, further studies are required to verify these results. Moreover, polysaccharides composed of glucose, 2-deoxy-glucose, arabinose, xylose, mannose, and glucosamine from A. auricula were shown to effectively treat rats with type 2 diabetes mellitus by inhibiting the oxidative stress response signaling pathway (Lu et al. 2018a ), a pathological mechanism associated with diabetes (Tiwari et al. 2013) .
Research conducted previously provides evidence that the extraction method of Auricularia polysaccharides is critical to their anti-diabetic properties and glucose tolerance (Yuan et al. 1998b ). According to the study, in contrast to the anti-diabetic properties of crude polysaccharides and neutral polysaccharide fractions extracted from A. auricula-judae, the acidic polysaccharide fraction derived from A. auricula-judae had no impact on diabetes when tested on mice. The administration of crude polysaccharides but not neutral polysaccharides improved glucose tolerance (Yuan et al. 1998b ). In addition to maintaining blood glucose levels, Auricularia has also been associated with the treatment of nerve damage linked to diabetes. Aldose Reductase Inhibitors are a drug used for the treatment of this type of nerve damage and A. auricula-judae polysaccharide extracts exhibited similar actions to Aldose Reductase inhibitory activity, suggesting its application as an anti-diabetic drug (Wu & Xu 2015) .
Additional bioactive compounds and their functions

Proteins
After polysaccharides, proteins are the most abundant bio-compounds in Auricularia species representing its proximate composition. Proximate composition analysis of A. auriculajudae has shown that it contains 8.36% of proteins and 33.04% of total proteins are composed of essential amino acids (Afiukwa et al. 2015) . Some of the proteins and peptide sequences isolated from Auricularia appear to have medical and pharmaceutical properties similar to polysaccharides (Sheu et al. 2004 , Agyei & Danquah 2011 . The peptide sequences from Auricularia species that have pharmacological properties are called bioactive peptides (Agyei & Danquah 2011). An example of a bioactive protein is an immunomodulatory protein extracted from the basidiocarp of A. polytricha found to have immunostimulant abilities (Sheu et al. 2004) . Further experimentation has shown that the immunomodulatory proteins isolated from A. polytricha have properties of pharmaceutical and stable immune stimulants such as tolerance to acids and alkali, heat and freezing, and dehydration (Chang et al. 2007 ).
Exo-biopolymers
Exo-biopolymers, also known as exopolymers, are biopolymers generated by an organism, such as a fungus, and are secreted into the environment. In particular, Auricularia species are known to produce a wide range of biopolymers (Yang et al. 2002 , Xu & Yun 2003 , Jeong et al. 2007 ). These compounds have been shown to have potential in the treatment of hyperlipidemia, in a study carried out on hyperlipidemic rats (Yang et al. 2002) . In these rats, an exo-biopolymer, isolated from A. polytricha and composed of carbohydrates (77.5%) and proteins (22.5%), reduced plasma LDL cholesterol by 70% in rats (Yang et al. 2002) .
Melanin
Apart from the major edible and medicinal components of Auricularia species, melanin is one compound that has applications in the food industry, as well as the pharmacological, medicinal, and cosmetic fields, with potential for novel claims within these industries (Hyde et al. 2010 , Sun et al. 2016 . Submerged cultures of A. auricula with glucose, tyrosine, peptone, and CaCO 3 additives is a reliable method for the large-scale production of natural melanin (Zhang et al. 2015b ). Sun et al. (2016) demonstrated that the use of the yeast extracts tyrosine and lactose during the microbial submerged fermentation process of the melanin extraction and purification protocol could significantly increase the amount of purified melanin by A. auricula. The capacity of A. auricula submerged cultures (with tyrosine additives) to produce melanin pigments has also been demonstrated (Wu et al. 2018 , Zou & Ma 2018 . Thus, A. auricula also has applications in the food industry as a colorant (Zou & Ma 2018) . Additionally, a mix of methanol (1%), peanut oil (0.25%), and stearic acid (1.0%) or palmitic acid (0.5%) has been shown to increase the biosynthesis of melanin 1.53 times that of submerged cultures of A. auricula (Wu et al. 2018) . Melanin isolated from A. auricula also possesses anti-microbial or anti-biofilm properties, as illustrated by the inhibition of biofilms formed by E. coli K-12, Pseudomonas aeruginosa PAO1, and Pseudomonas fluorescens P-3 (Bin et al. 2012).
Adenosine
Adenosine is a nucleoside which is a major constituent of DNA and RNA. Adenosine from A. auricula extracted using water, methanol, or butanol showed a potent inhibitory effect for rabbit platelet aggregation and suggests anti-platelet functions (Murata et al. 2004) . Auricularia auricula and A. polytricha with adenosine contents of 133 and 154 µg/g of dry fungus, respectively, have been shown to inhibit ADP-induced aggregation of platelets both on a rat model and in human platelets, thereby indicating their potential for application in humans (Agarwal et al. 1982 ). These anti-platelet or anti-aggregant properties are of great interest for their capacity to inhibit thrombus formation, and thus can be used as a potential drug therapy for cerebrovascular or cardiovascular diseases.
Polyphenolic compounds
Ethanol extract of A. auricula containing polyphenolic compounds [16% (g/g dry weight) without polysaccharides, water-soluble fiber, and proteins] was found to decrease total cholesterol levels and atherosclerosis indexes in mice, indicating the hypocholesterolemic effects of these polyphenolic compounds (Chen et al. 2011 ). According to the authors, the study provides evidence for the application of A. auricula not only to prevent but also to treat cardiovascular disease.
Conclusion and Future Perspectives
Among the bioactive chemicals of Auricularia species, polysaccharides are the most promising, possessing anti-cancer, anti-bacterial, anti-viral, immunomodulatory, antioxidant, hypoglycemic, and anti-hypercholesterolemic properties. In addition, exo-biopolymers, melanin, polyphenolic compounds, and proteins have also been recognized as potential pharmacological agents that can be further developed into novel drugs for treating human disease. However, proteins have been shown to be of great potential as a source of novel compounds and treatments, and thus should be more extensively researched in the future. The bioactive compounds of Auricularia species hold promise for the development of future drug therapies and supplements for many human diseases. However, much of the research regarding these treatments has been conducted on animal models and thus requires further validation using clinical trials and human patients. (Sone et al. 1978 , Misaki et al. 1981 , Misaki & Kakuta 1995 , 2.3. AAPS-1, 2.4. AAFRC (Song & Du 2012a, b) . (Sone et al. 1978 , Misaki et al. 1981 , Ukai et al. 1982 , 1983a , 2.2. AAG (Ma et al. 2008 (Ma et al. , 2010 
2011)
A. auriculajudae * Dried fruit body → 0 9% NaCl (aq) (24h) → Residue → hot water extract (120°C/20 min ) → precipitated with Cetylpyridinium chloride (CPC) → supernatant → precipitated with EtOH → Glucan I Glucan I β-(1→3)-linked D-glucopyranosyl backbone [two out of three glucose residues of the backbone were substituted with single glucopyranose at C-6] (Fig.  2.1 ). −10.1° (c=1.5, 0.5M NaOH). Neutral, water-soluble.
2.3% yield. m.w. 1.4 × 10 6
Anti-tumor activity on sarcoma 180 cells implanted ICR-JCR mice i.p., 8 mg× 10 days Average tumor weight 96.6% (Sone et al. 1978 , Misaki et al. 1981 , Misaki & Kakuta 1995 A. auriculajudae * Dried fruit body → 0 9% NaCl (aq) (24h) → residue → hot water extraction (120°C/20 min ) → residue → hot alkali extraction (1M NaOH/65°C/2h) → residue → Glucan II Glucan II β-(1→3)-linked D-glucopyranosyl backbone [three out of four glucose residues of the backbone were substituted with single glucopyranose units, and (l→6)-D glucosidic linked short side chains (very few) at C-6] (Fig. 2.2) .
Water, alkali (2M NaOH) or Me 2 SO insoluble. 49% yield. m.w. ~ 6 × 10 3 Anti-tumor activity on sarcoma 180 cells implanted ICR-JCR mice i.p., 10 mg× 10 days Average tumor weight 18.9% (Sone et al. 1978 , Misaki et al. 1981 , Misaki & Kakuta 1995 28 Heteropolysaccharide: α-(1→3)-linked Dmannopyranosyl backbone (Fig. 3.1) substituted with D-xylopyranose, Dmannopyranose, Dglucopyranosuronic acid residues at C-2 or C-6 and small proportion of (1→3)linked D-glucopyranose. Anti-tumor activity on sarcoma 180 cells implanted ICR-JCR mice i.p., 10 mg× 10 days Average tumor weight 18.5% (Sone et al. 1978 , Misaki et al. 1981 A. auriculajudae * Dried fruit body → NaCl (aq) (24h) → Residue → hot water extraction (120°C/20 min ) → residue → hot alkali (1M NaOH/65°C/2h) extract → precipitated with EtOH → heteropolysaccharide Alkali soluble. Molar ratio of D-xylose: Dmannose: D-glucose: Dglucuronic acid = 1: 2.1: 1: 0.6.
--- (Sone et al. 1978) 29 α-(1→3)-linked Dmannopyranosyl backbone ( ig 3 1) substituted with β-D-glucopyranosyluronic acid at C-2, single residue or short chains of β-Dxylopyranose at C-2, C-6 and small amount of (1→6)linked D-mannopyranose (and/or D-glucopyranose), branching Dmannopyranose at C-4, C-6. +31° (c=1, H 2 O). Me 2 SO slightly soluble. Molar ratio D-glucuronic acid:
D-xylose: Dmannose = 1: 0.5: 2.8. 4% yield. m.w. 3.7 × 10 5
Anti-tumor activity on sarcoma 180 cells implanted ddY male mice i.p., 25 mg× 10 days Average tumor weight 42% (Ukai et al. 1982 (Ukai et al. , 1983b Anti-inflammatory activity on Sprague (Ukai et al. 1983a) A. auriculajudae * Dried fruit body → hot ethyl acetate and methanol → Residue → 0% ethanol/water extract AAG β-(1→4)-linked Dglucopyranosyl backbone with β-(1→6)-linked Dglucopyranosyl side groups at C-6 ( Fig. 3.2) . Glucuronic acid may substitute on two adjacent glucose residues, or substitute alternate with one or more glucose residues. (Ma et al. 2008 (Ma et al. , 2010 30 
D-glucopyranosyl backbone substituted with single α-(1→6)-linked Dglucopyranose at C-6 on every six residues (Fig. 2.4 Table 4 Continued. *commercial strain; **abbreviated name of polysaccharide used in the original reference; i.m., intramuscular injection; i.p., intraperitoneal injection; i.v., intravenous injection; m.w., molecular weight; r.s., reference standard; p.o., oral administration; s.c., subcutaneous injection.
Auricularia species
Extraction
Chemical structure Chemical and physical properties 
A. polytricha
Dried fruit body → hot 95% EtOH extract ( 5°C/3 times/3h) → residue → hot water extract ( 5°C/3 times/3h) → precipitated with 95% EtOH → APPsA-1**, APPsB-1**, APPsB-2**, APPsC-1** Antioxidant activity in vitro (1) OH − (2) Fe 3+ radical scavenging activity 4 mg/ml (r.s.: ascorbic acid, ethylenediaminete traacetic acid) Scavenging rate APPsC-1, APPsB-2, APPs 1 (1) ≈ 0-90% (2) ≈60-80%. APPsA-1 (1) ≈20-30% (2) 
